Literature DB >> 27720361

Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers.

C Dunyach-Remy1, C Courtais-Coulon2, C DeMattei3, N Jourdan4, S Schuldiner5, A Sultan6, C Carrière7, S Alonso3, A Sotto8, J-P Lavigne9.   

Abstract

AIMS: Nasal carriage of Staphylococcus aureus in diabetic patients may be a risk factor for diabetic foot lesion infections. The aims of this study were to compare the genotypic profiles of S. aureus strains isolated from nares and diabetic foot ulcers (DFUs) using microarray technology.
METHODS: Patients were included if they were admitted for diabetic foot infection (DFI) at any of three diabetology departments of Montpellier and Nîmes University Hospitals between 1 September 2010 to 30 June 2012. All S. aureus isolates were analyzed using oligonucleotides arrays; S. aureus resistance and virulence genes were determined and each isolate was affiliated to a clonal complex.
RESULTS: The prevalence of S. aureus nasal carriage among the 276 included patients was 39.5% (n=109), while 36.6% (n=101) had S. aureus at both sites (nares and foot wounds) and, of these patients, 65.3% of patients harboured the same strain at both sites. In addition, the spread of the methicillin-resistant S. aureus (MRSA) ST398 clone in DFI and its tropism for bone were also further confirmed.
CONCLUSION: These findings appear to provide new arguments in favour of the systematic detection of nasal S. aureus carriage to anticipate the management of DFI.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Clonal complexes; Diabetic foot ulcer; Infection; Nasal carriage; Oligonucleotide array; Staphylococcus aureus

Mesh:

Year:  2016        PMID: 27720361     DOI: 10.1016/j.diabet.2016.09.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

1.  Comparative Microbiological and Whole-Genome Analysis of Staphylococcus aureus Populations in the Oro-Nasal Cavities, Skin and Diabetic Foot Ulcers of Patients With Type 2 Diabetes Reveals a Possible Oro-Nasal Reservoir for Ulcer Infection.

Authors:  Brenda A McManus; Blánaid Daly; Ioannis Polyzois; Pauline Wilson; Gráinne I Brennan; Tanya E Fleming; Liam D Grealy; Marie-Louise Healy; David C Coleman
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

2.  The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis.

Authors:  Helen J Stacey; Caitlin S Clements; Susan C Welburn; Joshua D Jones
Journal:  Acta Diabetol       Date:  2019-04-06       Impact factor: 4.280

Review 3.  Human Infection of Methicillin-Susceptible Staphylococcus aureus CC398: A Review.

Authors:  Kevin Bouiller; Xavier Bertrand; Didier Hocquet; Catherine Chirouze
Journal:  Microorganisms       Date:  2020-11-05

Review 4.  Bacterial Interactions in the Context of Chronic Wound Biofilm: A Review.

Authors:  Benjamin A R N Durand; Cassandra Pouget; Chloé Magnan; Virginie Molle; Jean-Philippe Lavigne; Catherine Dunyach-Remy
Journal:  Microorganisms       Date:  2022-07-25

5.  Microbial Diversity of Chronic Wound and Successful Management of Traditional Chinese Medicine.

Authors:  Minfeng Wu; Yan Li; Dongjie Guo; Gang Kui; Bin Li; Yu Deng; Fulun Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-09       Impact factor: 2.629

Review 6.  Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections.

Authors:  Adèle Sakr; Fabienne Brégeon; Jean-Louis Mège; Jean-Marc Rolain; Olivier Blin
Journal:  Front Microbiol       Date:  2018-10-08       Impact factor: 5.640

7.  Evaluation of the Use of Antibiofilmogram Technology in the Clinical Evolution of Foot Ulcers Infected by Staphylococcus aureus in Persons Living with Diabetes: A Pilot Study.

Authors:  Albert Sotto; Frédéric Laurent; Sophie Schuldiner; Julien Vouillarmet; Stéphane Corvec; Pascale Bemer; David Boutoille; Catherine Dunyach-Rémy; Jean-Philippe Lavigne
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.